Your shopping cart is currently empty

D5B is an effective and selective PD-L1 inhibitor that has been modified with DBCO. It degrades PD-L1 in 4T1 and B16-F10 tumor cells with EC50 values of 5.4 μM and 6.2 μM, respectively. D5B can block the PD-L1/PD-1 interaction and exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | D5B is an effective and selective PD-L1 inhibitor that has been modified with DBCO. It degrades PD-L1 in 4T1 and B16-F10 tumor cells with EC50 values of 5.4 μM and 6.2 μM, respectively. D5B can block the PD-L1/PD-1 interaction and exhibits antitumor activity. |
| In vitro | D5B (0-10 μM; 24 hours) degrades PD-L1 in 4T1 and B16-F10 tumor cells, with EC50 values of 5.4 μM and 6.2 μM, respectively. Additionally, D5B (0-5 μM; 48 hours) significantly reduces the abundance of PD-L1 on the cell membrane surface in IFN-γ treated and azide-labeled 4T1 and B16-F10 tumor cells. |
| In vivo | Administered intravenously at a single dose of 5 mg/kg, D5B exhibits anti-tumor activity in mouse tumor models, with enhanced efficacy when combined with radiotherapy. (D5B refers to PCPGd@D5B nanoparticles). |
| Molecular Weight | 983.15 |
| Formula | C58H66N2O12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.